Search by Drug Name or NDC
NDC 00078-0736-10 ALOMIDE 1 mg/mL Details
ALOMIDE 1 mg/mL
ALOMIDE is a OPHTHALMIC SOLUTION/ DROPS in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is LODOXAMIDE TROMETHAMINE.
MedlinePlus Drug Summary
Ophthalmic lodoxamide is used to treat redness, burning, itching, and swelling of the eyes that is caused by allergic reactions. Lodoxamide is in a class of medications called mast cell stabilizers. It works by preventing allergic reactions.
Related Packages: 00078-0736-10Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Lodoxamide Ophthalmic
Product Information
| NDC | 00078-0736 |
|---|---|
| Product ID | 0078-0736_4e55e8fe-2c2c-4661-9713-cbcb6fa9ea7c |
| Associated GPIs | |
| GCN Sequence Number | 044695 |
| GCN Sequence Number Description | lodoxamide tromethamine DROPS 0.1 % OPHTHALMIC |
| HIC3 | Q6U |
| HIC3 Description | EYE MAST CELL STABILIZERS |
| GCN | 69079 |
| HICL Sequence Number | 021033 |
| HICL Sequence Number Description | LODOXAMIDE TROMETHAMINE |
| Brand/Generic | Brand |
| Proprietary Name | ALOMIDE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | lodoxamide tromethamine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SOLUTION/ DROPS |
| Route | OPHTHALMIC |
| Active Ingredient Strength | 1 |
| Active Ingredient Units | mg/mL |
| Substance Name | LODOXAMIDE TROMETHAMINE |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Pharmaceutical Class | Decreased Histamine Release [PE], Mast Cell Stabilizer [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA020191 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00078-0736-10 (00078073610)
| NDC Package Code | 0078-0736-10 |
|---|---|
| Billing NDC | 00078073610 |
| Package | 1 BOTTLE in 1 CARTON (0078-0736-10) / 10 mL in 1 BOTTLE |
| Marketing Start Date | 2022-08-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |